MiR-15b-5p Regulates Collateral Artery Formation by Targeting AKT3 (Protein Kinase B-3)

Ling-Ping Zhu1, Ji-Peng Zhou1, Jia-Xiong Zhang1

  • 1From the Department of Cardiovascular Medicine, Xiangya Hospital, Central South University, Changsha, China (L.-P.Z., J.-P.Z., J.-Y.W., Z.-Y.W., M.P., L.-F.L., L.C., G.-G.Z.); Department of Geriatric Medicine, Xiangya Hospital, Central South University, Changsha, China (J.-X.Z., C.-C.L., Y.-P.B.); and Department of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha, China (K.-K.W.).

Abstract

Insights

Low expression of microRNA-15b-5p (miR-15b-5p) indicates good coronary collateral artery function. This microRNA regulates blood vessel formation and may be a therapeutic target for ischemic diseases.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Vascular Biology

Background:

  • Coronary heart disease (CHD) severity correlates with collateral artery development.
  • Identifying biomarkers for collateral function is crucial for patient stratification.
  • MicroRNAs (miRNAs) play roles in vascular homeostasis and disease.

Purpose of the Study:

  • To identify circulating miRNAs associated with coronary collateral artery function in severe CHD.
  • To elucidate the in vivo and in vitro mechanisms of action of identified miRNAs.
  • To explore potential therapeutic applications of these miRNAs in ischemic conditions.

Main Methods:

  • Circulating miRNA expression profiling in CHD patients.
  • Murine hindlimb ischemia model for in vivo studies.
  • In situ hybridization, cell migration, and proliferation assays for in vitro analysis.
  • Identification of miRNA targets using molecular biology techniques.

Main Results:

  • miR-15b-5p was identified as a circulating miRNA with low expression in patients with sufficient collateral artery function.
  • In vivo, miR-15b-5p expression was downregulated after femoral artery ligation, and its overexpression inhibited arteriogenesis and angiogenesis.
  • In vitro, miR-15b-5p modulated endothelial cell migration and proliferation, targeting AKT3 (protein kinase B-3).
  • AKT3 deficiency suppressed arteriogenesis and blood perfusion recovery in mice.

Conclusions:

  • Circulating miR-15b-5p serves as a biomarker for differentiating collateral artery development in CHD.
  • miR-15b-5p is a key regulator of arteriogenesis and angiogenesis.
  • miR-15b-5p represents a potential therapeutic target for ischemic diseases.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.3K